Intrinsic Value of S&P & Nasdaq Contact Us

Nippon Shinyaku Co., Ltd. NPPNY OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • JP • USD

SharesGrow Score
90/100
6/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Nippon Shinyaku Co., Ltd. (NPPNY) trades at a trailing P/E of 0.1. Trailing earnings yield is 1,428.57%.

Criteria proven by this page:

  • VALUE (100/100, Pass) — P/E is below market average (0.1); earnings yield beats bond yields (1,428.57%).
  • Trailing Earnings Yield 1,428.57% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.

Overall SharesGrow Score: 87/100 with 6/7 criteria passed.

SharesGrow 7-Criteria Score
90/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
N/A
No coverage
PAST
100/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
MOAT
82/100
→ Income
GROWTH
73/100
→ Income
INCOME
85/100
→ Income

Valuation Snapshot — NPPNY

Valuation Multiples
P/E (TTM)0.1
Forward P/EN/A
PEG Ratio0.00
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.01
EV/EBITDA0.0
Per Share Data
EPS (TTM)$120.82
Book Value / Share$0.00
Revenue / Share$594.58
FCF / Share$0.00
Yields & Fair Value
Earnings Yield1,428.57%
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2015 $23.53 $84.21B $6.34B 7.5%
2016 $43.61 $98.78B $11.75B 11.9%
2017 $48.08 $101.45B $12.95B 12.8%
2018 $60.51 $114.72B $16.3B 14.2%
2019 $62.60 $116.64B $16.87B 14.5%
2020 $72.53 $121.89B $19.54B 16%
2021 $92.74 $137.48B $24.99B 18.2%
2022 $84.68 $144.18B $22.81B 15.8%
2023 $95.96 $148.26B $25.85B 17.4%
2025 $120.82 $160.23B $32.56B 20.3%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message